Enhancement of Anti-HIV-1 Activity by Hot Spot Evolution of RANTES-Derived Peptides
Authors:
- Massimiliano SecchiMSMassimiliano Secchi
- Renato LonghiRLRenato Longhi
- Lia VassenaLVLia Vassena
- Francesca SironiFSFrancesca Sironi
- Stephan GrzesiekSGStephan Grzesiek
- Paolo LussoPLPaolo Lusso
- Luca VangelistaLVLuca Vangelista
- 1 December 2012
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 19 (12) , 1579-1588
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Clinical use of CCR5 inhibitors in HIV and beyondJournal of Translational Medicine, 2011
- Targeted Amino-Terminal Acetylation of Recombinant Proteins in E. coliPLOS ONE, 2010
- Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicideProceedings of the National Academy of Sciences, 2008
- Recognition of RANTES by Extracellular Parts of the CCR5 ReceptorJournal of Molecular Biology, 2007
- Engineering Chemokines to Develop Optimized HIV InhibitorsCurrent Protein & Peptide Science, 2005
- The structural biology of type I viral membrane fusionNature Reviews Molecular Cell Biology, 2003
- Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcεRIαNature, 2000
- The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytesProceedings of the National Academy of Sciences, 1997
- The role of a mutant CCR5 allele in HIV–1 transmission and disease progressionNature Medicine, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995